Additionally, participants originating from Europe compared with sub‐Saharan Africa and those starting bPI regimens compared with NNRTI regimens had a lower risk, and those with an AIDS diagnosis before starting ART had a higher risk, as did those with a higher pre‐ART viral load and lower pre‐ART CD4. This evidence concerns the gene CD4 and AIDS.